Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Kocisko

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Methods in Enzymology|October 19, 2006
Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategiesDavid A Kocisko, Byron Caughey
Journal of Virology|December 28, 2005
Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoDavid A Kocisko, Byron Caughey
Antimicrobial Agents and Chemotherapy|September 29, 2006
Enhanced antiscrapie effect using combination drug treatmentDavid A Kocisko, Byron Caughey, John D Morrey, et al.
Journal of Wildlife Diseases|April 12, 2012
Assessment of prospective preventive therapies for chronic wasting disease in mule deerLisa L Wolfe, David A Kocisko, Byron Caughey, et al.
The Journal of General Virology|July 23, 2004
Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in miceDavid A Kocisko, John D Morrey, Richard E Race, et al.
Journal of Virology|September 13, 2003
New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural productsDavid A Kocisko, Gerald S Baron, Richard Rubenstein, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
A porphyrin increases survival time of mice after intracerebral prion infectionDavid A Kocisko, Winslow S Caughey, Richard E Race, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2007
Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activityWinslow S Caughey, Suzette A Priola, David A Kocisko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in thai soldiers receiving monthly prophylaxisMichael D Edstein, David A Kocisko, Douglas S Walsh, et al.
Protein Science : a Publication of the Protein Society|February 3, 2006
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formationRoger A Moore, Christian Herzog, John Errett, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Methods in Enzymology|October 19, 2006
Searching for anti-prion compounds: cell-based high-throughput in vitro assays and animal testing strategiesDavid A Kocisko, Byron Caughey
Journal of Virology|December 28, 2005
Mefloquine, an antimalaria drug with antiprion activity in vitro, lacks activity in vivoDavid A Kocisko, Byron Caughey
Antimicrobial Agents and Chemotherapy|September 29, 2006
Enhanced antiscrapie effect using combination drug treatmentDavid A Kocisko, Byron Caughey, John D Morrey, et al.
Journal of Wildlife Diseases|April 12, 2012
Assessment of prospective preventive therapies for chronic wasting disease in mule deerLisa L Wolfe, David A Kocisko, Byron Caughey, et al.
The Journal of General Virology|July 23, 2004
Evaluation of new cell culture inhibitors of protease-resistant prion protein against scrapie infection in miceDavid A Kocisko, John D Morrey, Richard E Race, et al.
Journal of Virology|September 13, 2003
New inhibitors of scrapie-associated prion protein formation in a library of 2000 drugs and natural productsDavid A Kocisko, Gerald S Baron, Richard Rubenstein, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
A porphyrin increases survival time of mice after intracerebral prion infectionDavid A Kocisko, Winslow S Caughey, Richard E Race, et al.
Antimicrobial Agents and Chemotherapy|August 22, 2007
Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activityWinslow S Caughey, Suzette A Priola, David A Kocisko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in thai soldiers receiving monthly prophylaxisMichael D Edstein, David A Kocisko, Douglas S Walsh, et al.
Protein Science : a Publication of the Protein Society|February 3, 2006
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formationRoger A Moore, Christian Herzog, John Errett, et al.
Pageof 2